European Healthtech startup funding raised during August 2016.
In August 2016, 31 European Healthtech companies raised a combined €184M across 31 funding rounds, down 54.6% versus August 2015. Germany led by capital raised, and Fountain Healthcare Partners was the most active investor. Data as of 9 Jul 2026.
1 exit.
| Company | Stage | Date | Amount |
|---|---|---|---|
| IOmx Therapeutics | Series A | Aug 2016 | €40M |
| Spineart | Growth/Late | Aug 2016 | €30M |
| Artios | Series A | Aug 2016 | €29M |
| Vivasure Medical | Series C |
| Aug 2016 |
| €16M |
| Inflazome | Series A | Aug 2016 | €15M |
| Rigontec | Series A | Aug 2016 | €14M |
| Eyevensys | Series A | Aug 2016 | €9.0M |
| H4D | Series B | Aug 2016 | €6.7M |
| Seventeen | Series A | Aug 2016 | €4.2M |
| LeUnited Kingdomos Biotech | Early VC | Aug 2016 | €3.5M |
| Reapplix | Series A | Aug 2016 | €2.7M |
| Bioxis Pharmaceuticals | Early VC | Aug 2016 | €2.5M |
| Mint Solutions | Grant | Aug 2016 | €2.4M |
| Medherant | Early VC | Aug 2016 | €1.8M |
| Oncovet Clinical Research | Early VC | Aug 2016 | €1.3M |
